phosphorylethanolamine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conceição, TO | 1 |
| Cabral, L | 1 |
| Laveli-Silva, MG | 1 |
| Pacheco, JC | 1 |
| Alves, MG | 1 |
| Rabelo, DC | 1 |
| Laiso, R | 1 |
| Maria, DA | 1 |
1 other study available for phosphorylethanolamine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
New potential antiproliferative monophosphoester 2-aminoethyl dihydrogen phosphate in K-562 and K-562 MDR
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Death; Cell Line, | 2021 |